Tracy Campbell Accardi joined Medtronic as the vice president of Surgical Robotics R&D in April 2019. Prior to Medtronic, Tracy was the global vice president of R&D for the Breast Health and Skeletal Health Division of Hologic, a developer, manufacturer and supplier of diagnostic and medical imaging systems in the women’s health space. Hologic was first to bring breast tomosynthesis to market globally, with the ability to detect 20% to 65% more invasive cancers compared to standard 2D mammography imaging alone. Prior to Hologic, Tracy was the chief technology officer for OmniGuide Surgical, a late-stage commercial startup in the advanced surgical energy device space.
Prior to that role, Tracy was vice president of Global Research and Development for the Vascular Therapies division at Covidien. She oversaw more than 200 engineers in the United States and Japan and led the development of acute and chronic dialysis catheters, vascular compression devices, pharmaco-mechanical thrombolysis treatment catheters and vein ablation catheters. Over the course of her career, Tracy has worked for several major medical device companies, including Johnson & Johnson, Philips Healthcare (a subsidiary of Royal Philips Electronics), and GE Healthcare. She held executive-level leadership positions at all these companies, leading international teams of engineers and scientists to develop products and therapies in the neurovascular and cardiovascular spaces.
Tracy holds dual bachelor’s degrees in mechanical engineering and engineering and public policy from Carnegie Mellon University in Pittsburgh, Pa. She also earned her master’s degree in mechanical engineering from Rensselaer Polytechnic Institute in Troy, N.Y.
